• Publications
  • Influence
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses
Abstract Objectives. Alterations of BDNF signalling in major depression (MD) are supported by studies demonstrating decreased levels of the neurotrophin serum and plasma content in MD patients. WeExpand
  • 302
  • 18
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease
It has been recently demonstrated that the 43‐kDa transactive response (TAR)‐DNA‐binding protein (TARDBP) is the neuropathological hallmark of Frontotemporal Dementia (FTD) with ubiquitin‐positiveExpand
  • 202
  • 18
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease
SIR – Alzheimer's disease (AD) is a chronic brain disorder associated with specific pathological changes resulting in neurodegeneration and in progressive development of dementia. This disease isExpand
  • 242
  • 16
  • PDF
Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia
Dysregulation of the inflammatory response system has been linked to pathophysiology of schizophrenia.1,2 Evidence of immune activation has derived from the detection of abnormal levels ofExpand
  • 170
  • 15
  • PDF
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients
Several findings have suggested that the neurotrophin BDNF could contribute to clinical efficacy of antidepressant treatments. The purpose of this study was to analyse if ECT operates a modulation ofExpand
  • 168
  • 13
  • PDF
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.
BACKGROUND Depression has been associated with low brain-derived neurotrophic factor (BDNF) serum levels, while antidepressant drugs appear to mend this alteration. The purpose of this study was toExpand
  • 121
  • 10
  • PDF
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study.
BACKGROUND There is lack of data regarding BDNF serum levels in patients with obsessive-compulsive disorder (OCD). The aims of the present study were: 1) to assess the serum BDNF content in a sampleExpand
  • 71
  • 9
  • PDF
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases
Consistent evidence indicates the involvement of the brain-derived neurotrophic factor (BDNF) in neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD). In theExpand
  • 105
  • 7
  • PDF
Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses.
OBJECTIVE To determine whether peripheral biochemical markers (biomarkers) might differentiate patients with attention-deficit/hyperactivity disorder (ADHD) from non-ADHD individuals. METHOD WeExpand
  • 144
  • 6
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder
The brain-derived neurotrophic factor (BDNF) is involved not only in promoting neuronal outgrowth and differentiation, synaptic connectivity and neuronal repair, but also in modulating eatingExpand
  • 61
  • 6